Furthermore, delineating the dynamic changes and dual roles of the cGAS‐STING pathway across the AD continuum, from preclinical to dementia stages, will be critical for founding personalized immunomodulatory therapies. The gene discussed is STING1; the disease is Alzheimer disease.